A new multi-institutional project is studying cancer biology and care to identify why minority children have worse cancer outcomes compared to their white peers.
Researchers identify a lncRNA that provides insight into a key driver of prostate cancer — and a potential target for future therapy.
Researchers have discovered the process that allows immune suppressor cells to develop, suggesting a potential new way to bolster immunotherapy treatment.
The novel platform for chemoimmunotherapy eliminated colon cancer in 85 percent of treated mice.
A large randomized trial finds Keytruda given with chemotherapy resulted in 20 percent improved survival at one year.
A decadelong effort to genomically characterize multiple cancers begets a huge archive: 33 cancer types, 11,000 tumors and 27 new papers that explain the findings.